CRSP
CRISPR Therapeutics AG
Stock
$55.43−0.01 (−0.02%)Close Oct 2, 2026
- Stock-based compensation, 2025
- $72M
- YoY, 2025
- −16.3%
- 5-year CAGR
- +1.9%
- 10-year CAGR
- +34.7%
Stock-based compensation
Stock-based compensation by fiscal year
| Period | Stock comp | YoY |
|---|---|---|
| 2025 | $72M | −16.3% |
| 2024 | $87M | +6.8% |
| 2023 | $81M | −17.3% |
| 2022 | $98M | −4.3% |
| 2021 | $102M | +55.1% |
| 2020 | $66M | +49.8% |
| 2019 | $44M | +25.9% |
| 2018 | $35M | +85.4% |
| 2017 | $19M | +74.0% |
| 2016 | $11M | +194.4% |
| 2015 | $3.7M | +430.1% |
| 2014 | $695K | — |